Alvotech Holdings S.A Logo

Alvotech Holdings S.A

ALVO | LU

Overview

Corporate Details

ISIN(s):
LU2458332611
LEI:
222100DCZBOWV5DZ8372
Country:
Luxembourg
Address:
9, RUE DE BITBOURG, L-1273 LUXEMBOURG
Sector:
Health Care
Industry:
Biotechnology

Description

We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do. We have a deep appreciation for the positive impact biologic medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines are revolutionizing the way we treat diseases and improve patient lives. It is our aim to broaden the availability of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars. Our commitment to the promise of biosimilars is foundational to our approach, our culture and the strong sense of purpose that inspires us to work smarter and faster towards this mission. We are driven by passion - if there is a proven biologic medicine, we believe it should be accessible to all patients in need.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-26 10:01
Directors' Dealings
Notification Managers Transaction - Alvotech - Alvogen Lux Holdings S.à r.l.
English 84.5 KB
2025-05-20 09:24
Directors' Dealings
Managers' Transaction Notification R. Davies (20250516)
English 84.1 KB
2025-05-13 17:44
Regulatory News Service
pdf1278040195305217091
English 84.5 KB
2025-05-12 10:18
Regulatory News Service
Managers' Transaction Notification (20250512)
English 55.7 KB
2025-04-30 20:07
Regulatory News Service
222100DCZBOWV5DZ8372-2024-12-31-en (2)
English 1.3 MB
2025-04-30 20:07
Regulatory News Service
4be7257a-c4d2-4fa3-bc77-2b60162f8a38
English 10.0 MB
2025-01-15 22:00
Directors' Dealings
ATP Holdings ehf. - Managers' Transaction Notification (PCA)
English 49.4 KB
2024-12-30 23:41
Directors' Dealings
pdf5009312744798760428 (1)
English 49.5 KB
2024-10-30 12:30
Earnings Release
Alvotech to Report Financial Result..
Icelandic 3.9 KB
2024-10-30 12:30
Earnings Release
Alvotech to Report Financial Result..
English 5.8 KB
2024-10-10 10:01
Regulatory News Service
European Medicines Agency Confirms Acceptance of Marketing Application for AVT0…
Icelandic 8.7 KB
2024-10-10 10:01
Regulatory News Service
European Medicines Agency Confirms Acceptance of Marketing Application for AVT0…
English 14.4 KB
2024-10-01 20:03
Interim Report
Unaudited Consolidated Financial Statements Q2 2024
English 345.5 KB
2024-08-29 23:22
Registration Form
Registration Statement Declared Effective
Icelandic 1.3 KB
2024-08-29 23:22
Prospectus
Registration Statement Declared Effective
English 1.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hiron-Trade Investments & Industrial Buildings Ltd. Israel HRON
Human Stem Cells Institute PJSC Logo Human Stem Cells Institute PJSC Russian Federation ISKJ
Human Xtensions Ltd. Logo Human Xtensions Ltd. Israel HUMX
Hybrigenics SA Logo Hybrigenics SA France ALHYG
Hyloris Pharmaceuticals SA Logo Hyloris Pharmaceuticals SA Belgium HYL
Ikonisys S.A. Logo Ikonisys S.A. France ALIKO
IMCB PJSC Logo IMCB PJSC Russian Federation GEMA
Inify Laboratories AB Logo Inify Laboratories AB Sweden INIFY
Innate Pharma Logo Innate Pharma France IPH
IntegraGen Logo IntegraGen France ALINT